Medicine, Health & Food
Volume: 115 , Issue: 1 , December Published Date: 19 December 2022
Publisher Name: IJRP
Views: 418 , Download: 352 , Pages: 235 - 239
DOI: 10.47119/IJRP10011511220224306
Publisher Name: IJRP
Views: 418 , Download: 352 , Pages: 235 - 239
DOI: 10.47119/IJRP10011511220224306
Authors
# | Author Name |
---|---|
1 | Yoga Akbar Arifandi |
2 | Alfian Nur Rosyid |
3 | Danti Nur Indiastuti |
4 | Wiwin Is Effendi |
Abstract
Coronavirus disease 2019 (COVID-19), is an infectious disease with various clinical presentation from asymptomatic to severe pneumonia and death. It is caused by the infection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). One of the important mechanisms that underlies the severe respiratory syndrome of COVID-19 is the oxidant-antioxidant imbalances owing to the inflammatory response and excessive oxidative stress. The antioxidant defense system plays a role in balancing these excessive reactive species. This literature study aims to review several therapeutic approaches particularly antioxidative agents that may be favorable in the treatment of COVID-19.